The Ras–MAPK pathway is frequently deregulated in tumours arising from epithelial tissues (e.g. carcinomas and melanoma) as a result of genetic alterations and upstream activation of cell surface growth factor receptors (e.g. EGFR). The gene discussed is EGFR; the disease is neoplasm.